Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Popular anti-diabetes and obesity drug Mounjaro has been launched in India in a single-dose vial. While it has already been ...

Eli Lilly has launched Mounjaro in India, a groundbreaking weight loss and diabetes drug, at a fraction of its US price. The ...

Eli Lilly and Company (India) has launched 'Mounjaro,' a novel medication for obesity and type 2 diabetes, after receiving ...

Eli Lilly (LLY) launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk (NVO) for a ...

Lilly reported earlier this month that its revenue in the latest fiscal quarter jumped 45% with its new products contributing more than $3.1 billion, driven mainly by strong demand for Mounjaro ...

“I had no idea this could happen,” he said, noting that he plans to file a lawsuit against Mounjaro drugmaker Lilly and Company. Sabellico pictured the first month he was on Ozempic. He lost ...

A new study funded by Eli Lilly reports that people without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide. The study used Mounjaro, which is not yet approved ...

Of course, Lilly's most important new products are diabetes treatment Mounjaro and weight management medicine Zepbound, which share the active ingredient tirzepatide. In 2024, Eli Lilly's revenue ...

Eli Lilly's weight-loss drugs include Mounjaro and Zepbound.Sandy Huffaker for The Washington Post/Getty Images Weight-loss drugs such as Ozempic and Zepbound cost $900 to $1,500 for a month's supply.